Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ESSA Pharma Inc. (NASDAQ: EPIX).

Full DD Report for EPIX

You must become a subscriber to view this report.


Recent News from (NASDAQ: EPIX)

ESSA Pharma reports Q2 results
ESSA Pharma (NASDAQ: EPIX ): Q2 EPS of -$0.83 Press Release More news on: ESSA Pharma, Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: May, 14 2018 23:44
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018
HOUSTON and VANCOUVER, May 14, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial res...
Source: PR Newswire
Date: May, 14 2018 19:15
Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements
HOUSTON and VANCOUVER , May 10, 2018 /PRNewswire/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (TSX-V: EPI, Nasdaq: EPIX), a pre-clinical stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced today that it received a notic...
Source: PR Newswire
Date: May, 10 2018 17:05
ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018
HOUSTON and VANCOUVER , April 26, 2018 /PRNewswire/ - ESSA Pharma Inc. (TSX-V: EPI, NASDAQ: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, today announced that David R. Parkinson ,...
Source: PR Newswire
Date: April, 26 2018 07:00
ESSA Pharma Inc. Announces Completion of Share Consolidation
ESSA Pharma Inc. Announces Completion of Share Consolidation Canada NewsWire HOUSTON, TX and VANCOUVER, April 25, 2018 HOUSTON , TX and VANCOUVER , April 25, 2018 /CNW/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage...
Source: Canada Newswire
Date: April, 25 2018 07:00
ESSA Pharma Enhances R&D Capabilities with Two New Key Hires
HOUSTON and VANCOUVER , April 24, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, announced today the appointments of Han-J...
Source: PR Newswire
Date: April, 24 2018 07:30
ESSA Pharma consolidating shares to meet Nasdaq requirements
ESSA Pharma (NASDAQ: EPIX ), hovering under $0.50/share for nine months, has announced it's going forward with a share consolidation . More news on: ESSA Pharma, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: April, 19 2018 19:49
ESSA Pharma Inc. Announces Share Consolidation
ESSA Pharma Inc. Announces Share Consolidation Canada NewsWire HOUSTON and VANCOUVER, April 19, 2018 HOUSTON and VANCOUVER , April 19, 2018 /CNW/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company foc...
Source: Canada Newswire
Date: April, 19 2018 19:38
ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants
HOUSTON and VANCOUVER, Feb. 23, 2018 /PRNewswire/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, hereby announces that on February 2...
Source: PR Newswire
Date: February, 23 2018 09:02
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 Canada NewsWire HOUSTON and VANCOUVER, Feb. 13, 2018 HOUSTON and VANCOUVER , Feb. 13, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI...
Source: Canada Newswire
Date: February, 13 2018 17:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-163.053.103.10283.051,200
2018-08-153.06533.11373.11373.06531,335
2018-08-143.13513.093.16223.069912,214
2018-08-133.34413.1153.353.1157,580
2018-08-103.16393.16393.16393.1639192

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-16400400100.0000Short
2018-08-142,9006,90042.0290Short
2018-08-136145,73010.7155Cover
2018-08-10165628.5714Cover
2018-08-093501,63121.4592Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EPIX.


About ESSA Pharma Inc. (NASDAQ: EPIX)

Logo for ESSA Pharma Inc. (NASDAQ: EPIX)

Not available

 

Contact Information

     

     

    Current Share Structure

    • Issue and Outstanding: 1,455,094 - 04/25/2018

     


    Recent Filings from (NASDAQ: EPIX)

    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 15 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 11 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 08 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 26 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 25 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 24 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 20 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: March, 29 2018
    Amendment to the SC 13G filing
    Filing Type: SC 13G/AFiling Source: edgar
    Filing Date: March, 09 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: March, 06 2018

     

     


    Daily Technical Chart for (NASDAQ: EPIX)

    Daily Technical Chart for (NASDAQ: EPIX)


    Stay tuned for daily updates and more on (NASDAQ: EPIX)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: EPIX)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EPIX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of EPIX and does not buy, sell, or trade any shares of EPIX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/